Dipexium Pharmaceuticals (DPRX) Priced

Late-stage biotech developing a topical antibiotic for diabetic foot ulcer infections.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $1.25 0.00 (0.0%)
First Day Return 17.0%
Return from IPO -89.6%
 
Dipexium Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 02/06/2014
Offer Price $12.00
Price Range $12.00 - $14.00
Offer Shares (mm) 2.8
Deal Size ($mm) 33
 
IPO Data
IPO Date 03/12/2014
Offer Price $12.00
Price Range $12.00 - $14.00
Offer Shares (mm) 2.8
Deal Size ($mm) $33
 
Underwriters
more
Business Overview
Late-stage biotech developing a topical antibiotic for diabetic foot ulcer infections.
Late-stage biotech developing a topical antibiotic for diabetic foot ulcer infections.
more
Company Data
Headquarters New York, NY
Founded 2010
Employees 7
Website www.dipexiumpharmaceuticals.com
 

Performance vs. IPO Index (IPOUSA)